Live Breaking News & Updates on Convention On Pharmaceutical Ingredients

Stay updated with breaking news from Convention on pharmaceutical ingredients. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Why Indian pharma cos are investing in biologics

Precision and lower side effects make biologics the preferred choice in India's cancer treatment ....

Apitoria Pharma , Sanjay Chaturvedi , Mahesh Bhalgat , Jasper Morley , Poonam Patil , Aurobindo Pharma , Bejon Kumar Misra , Convention On Pharmaceutical Ingredients , Syngene International , Access Initiative Of India Foundation , Pharmaceutical Ingredients , Manipal Hospital , Senior Consultant , Lourdes Hospital , Drugs Intelligence Analyst , Gilead Science Yescarta , Professor Bejon Kumar Misra , Founder Director , Patient Safety , Access Initiative , Pharma Companies , Cancer Treatment , Pharmaceutical Companies , Convention On Pharmaceutical Ingredients ,

Biologics demand soars with predicted growth in capacity, says CPHI report

Biologics demand to reach 4,400 KL by 2027, with an 11.5% annual growth rate, says report
....

United States , Comunidad Autonoma De Cataluna , Tara Dougal , Fujifilm Diosynth , Patricia Seymour , Convention On Pharmaceutical Ingredients , Bioprocess Technology Group , Trak Database Services , Pharmaceutical Ingredients , Dawn Ecker , Managing Director , Bioprocess Technology , Contract Manufacturing Organizations , Content Director , Next Generation Manufacturing , Biologics Market , Convention On Pharmaceutical Ingredients , Phi Report ,

After revenue milestone, Samsung Biologics presses home its advantage

Samsung Biologics is investing in new production facilities and exploring opportunities in new business areas after milestone revenue in the third quarter. "Now is the time for us to prepare for the next phase with a new modality and overwhelming production capability," Samsung Biologics CEO John Rim said during a press conference on Wednesday, held in Barcelona in line with the company’s participatio. ....

Comunidad Autonoma De Cataluna , Samsung Biologics , Convention On Pharmaceutical Ingredients , Development Center At Samsung Biologics , Pharmaceutical Ingredients , Bio Campus , Min Ho Sung , Samsung Biologic , The Korea Herald , Orean News , Outh Korea News , Outh Korea News In English , Sia News , K Pop , 코리아 헤럴드 ,

Prestige Biopharma eyes complete value chain

BARCELONA, Spain – Prestige Biopharma, a Kospi-listed biopharmaceutical firm based in Singapore, said Tuesday it is seeking to complete its value chain of new drug development with its upcoming research center in Busan. “Prestige Biopharma’s research and development of antibody drugs will pick up speed after the company opens its new research center in Busan,” Prestige Biopharma Chairman Park . ....

Pusan Gwangyoksi , South Korea , Kyongsang Bukto , Comunidad Autonoma De Cataluna , Convention On Pharmaceutical Ingredients , Innovative Discovery Center , Prestige Biopharma , Biopharma Chairman Park So Yeon , Pharmaceutical Ingredients , North Chungcheong Province , Cancer Moonshot , The Korea Herald , Orean News , Outh Korea News , Outh Korea News In English , Sia News , K Pop , 코리아 헤럴드 ,

SK Pharmteco bets big on cell, gene therapy

BARCELONA, Spain SK Pharmteco, SK Inc.’s contract bio-manufacturing subsidiary, said the company’s burgeoning cell and gene therapy (CGT) business will become its new growth engine. “We continue to expand our CGT business, and the capacity we are building over the next years will allow us to grow this business,” SK Pharmteco CEO Joerg Ahlgrimm said during a press conference Tuesday held on . ....

United States , Comunidad Autonoma De Cataluna , Joerg Ahlgrimm , Sk Inc , Convention On Pharmaceutical Ingredients , Sk Group , Bio Investment Center , Pharmaceutical Ingredients , Breakthrough Medicines , The Korea Herald , Orean News , Outh Korea News , Outh Korea News In English , Sia News , K Pop , 코리아 헤럴드 ,